My watch list
my.bionity.com  
Login  

Evolva

Companies Evolva

Evolva SA, Switzerland

Evolva’s mission is to discover and provide innovative, sustainable ingredients for health, nutrition and wellness. Evolva uses biosynthetic and evolutionary technologies to create and optimise small molecule compounds and their production routes. We are active in consumer healthcare and nutrition a more

News Evolva

  • Evolva reaches milestone in BASF collaboration

    Evolva Holding SA announced that it has achieved a key milestone in its collaboration with BASF. The collaboration involves joint research on the design of novel and optimised biosynthetic routes for a natural product with crop protection potential. Evolva has produced a yeast strain that achieves a more

  • Evolva in collaboration with Ajinomoto Co

    Evolva Holding SA announced that it has entered into a collaboration agreement with Ajinomoto Co. Inc., Japan, for the joint development of novel fermentation production routes for a natural functional ingredient for application in Personal Care.  During the 3½ year collaboration, Ajinomoto Co will more

  • Evolva acquires resveratrol programme from Fluxome

    Evolva has agreed to acquire all of Fluxome's scientific and technical assets related to resveratrol and hire a small number of its employees, integrating the programme into Evolva’s Danish operations. Evolva will not take over Fluxome’s US sales and marketing organisation but will instead focus on more

All news on evolva

Market studies Evolva

  • Summit plc - Strategic SWOT Analysis Review

    Summit plc (Summit) is engaged in the discovery and development of novel drugs. It develops new medicines using its proprietary iminosugar drug discovery platform and currently has product portfolio of eight programmes with partners including BioMarin, Evolva, Orient Pharma, the Wellcome Trust and a more

  • Summit plc (SUMM) - Strategic SWOT Analysis Review

    Summit plc (Summit) is engaged in the discovery and development of novel drugs. It develops new medicines using its proprietary iminosugar drug discovery platform and currently has product portfolio of eight programmes with partners including BioMarin, Evolva, Orient Pharma, the Wellcome Trust and a more

Websites Evolva

Cytos Biotechnology - Board &Management

News Events Overview Rationale for Immunodrugs™ Strategy Board & Management Industry Collaborations Letter of the CEO History Overview Immunodrug™ Platform Immunodrug™ Manufacturing Scientific Collaborations Scientific Publications Pipeline Clinical Trials Disease Areas Overview Board & Management S more

Summit - SMT 15000: Biodefence

    Home About Us Seglin Technology Programmes Investors News Centre Careers Contact Us Programmes Pipeline BMN-195: DMD SMT 19969: C. difficile SEGLIN Programmes SMT C2100: Cancer SMT 14224: Diabetes SMT 15000: Biodefence Hepatitis C Anti-virals Other Programmes Home ... Programmes ... SEGLIN Progr more

Claus Bræstrup | Bavarian Nordic

Language: en / da Sitemap Downloads Contact  Search: Core Competences Pipeline Business Development Investor Join Us About Us Cancer Biodefence Infectious Diseases About Us Company Overview Management Board of Directors Asger Aamund Erling Johansen Claus Bræstrup Gerard van Odijk Anders Gersel Peder more

All websites on evolva

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE